Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases from Non-Small-Cell Lung Cancer: A Case Report and Review of Literature

BACKGROUND: Choroidal metastases being the sole presenting feature of lung cancer is rare. Erlotinib, a tyrosine kinase inhibitor (TKI), is used in the treatment of lung adenocarcinoma where tumor cells exhibit epidermal growth factor receptor (EGFR) mutations. We report a case of metastatic non-sma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ocul Oncol Pathol
Autors principals: Nair, Akshay Gopinathan, Asnani, Haresh T., Mehta, Vinod C., Mehta, Siddharth V., Pathak, Rima S., Palkar, Amit H., Gopinathan, Indumati
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2017
Matèries:
Case Series and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319000/
https://ncbi.nlm.nih.gov/pubmed/28275600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars